0001214659-19-006703.txt : 20191029
0001214659-19-006703.hdr.sgml : 20191029
20191029200821
ACCESSION NUMBER: 0001214659-19-006703
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191025
FILED AS OF DATE: 20191029
DATE AS OF CHANGE: 20191029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chang David D
CENTRAL INDEX KEY: 0001611024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 191177023
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-45997.xml
PRIMARY DOCUMENT
X0306
4
2019-10-25
0001737287
Allogene Therapeutics, Inc.
ALLO
0001611024
Chang David D
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
President and CEO
Common Stock
2019-10-25
4
J
false
9402
0.00
A
1173106
I
See footnote
Common Stock
2019-10-25
4
J
false
9391
0.00
A
2215354
D
Pro rata distribution of shares of the Issuer's common stock from VVAG Special Fund LLC (VVAG) to its members pursuant to a Rule 10b5-1 trading plan adopted by VVAG on March 29, 2019.
Securities held in the name of the Chang 2006 Family Trust.
Pro rata distribution of shares of the Issuer's common stock from VVAG LLC to its members.
/s/ Veer Bhavnagri, Attorney-in-Fact
2019-10-29